IL18BP and periodic fever-infantile enterocolitis-autoinflammatory syndrome: Recombinant IL-18 binding protein (IL-18BP) has been employed in treating AIFEC but has been tested in only a limited number of cases, often in combination with other anti-inflammatory agents [32, 33], complicating the interpretation of its efficacy.